Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial

Autor: Hannawi, Suad, Yan, Lixin, Saf Eldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Zhang, Miaomiao, Gao, Cuige, Chen, Yuanxin, Gai, Wenlin, Xie, Liangzhi
Zdroj: In eClinicalMedicine October 2023 64
Databáze: ScienceDirect